🟢 MBX Biosciences is trading 4.2% up today on company-specific rebound and pipeline optimism

MBX Biosciences is trading 4.2% up today at $60.77 as shares rebound from recent biotech sector volatility and risk-off pressure.

• The move appears to be a company-specific recovery driven by continued optimism regarding the firm's precision peptide pipeline following recent favorable trial updates.
• The stock is showing significant relative strength as the broader biotech sector (XBI) and major indices remain weak, suggesting today's gain is a technical rebound rather than a response to a fresh news catalyst.